Search results for CD90

Spark Red™ 718 anti-human CD90 (Thy1) (Flexi-Fluor™) Antibody, CD90, 5E10, BioLegend, 285208

Clone 5E10 recognizes an epitope on Thy-1 independent of its glycosylation, but is abolished under reducing conditions.4Additional reported (for the relevant formats) applications include: immunohistochemical staining of acetone-fixed frozen sections, immunoprecipitation1, and immunofluorescence3.

Spark Blue™ 550 anti-human CD90 (Thy1) (Flexi-Fluor™) Antibody, CD90, 5E10, BioLegend, 285252

Clone 5E10 recognizes an epitope on Thy-1 independent of its glycosylation, but is abolished under reducing conditions.4Additional reported (for the relevant formats) applications include: immunohistochemical staining of acetone-fixed frozen sections, immunoprecipitation1, and immunofluorescence3.

Spark NIR™ 685 anti-human CD90 (Thy1) (Flexi-Fluor™) Antibody, CD90, 5E10, BioLegend, 285588

Clone 5E10 recognizes an epitope on Thy-1 independent of its glycosylation, but is abolished under reducing conditions.4Additional reported (for the relevant formats) applications include: immunohistochemical staining of acetone-fixed frozen sections, immunoprecipitation1, and immunofluorescence3.

Spark Blue™ 574 anti-human CD90 (Thy1) (Flexi-Fluor™) Antibody, CD90, 5E10, BioLegend, 285158

Clone 5E10 recognizes an epitope on Thy-1 independent of its glycosylation, but is abolished under reducing conditions.4Additional reported (for the relevant formats) applications include: immunohistochemical staining of acetone-fixed frozen sections, immunoprecipitation1, and immunofluorescence3.

Spark YG™ 581 anti-human CD90 (Thy1) (Flexi-Fluor™) Antibody, CD90, 5E10, BioLegend, 285539

Clone 5E10 recognizes an epitope on Thy-1 independent of its glycosylation, but is abolished under reducing conditions.4Additional reported (for the relevant formats) applications include: immunohistochemical staining of acetone-fixed frozen sections, immunoprecipitation1, and immunofluorescence3.

Spark YG™ 593 anti-human CD90 (Thy1) (Flexi-Fluor™) Antibody, CD90, 5E10, BioLegend, 285569

Clone 5E10 recognizes an epitope on Thy-1 independent of its glycosylation, but is abolished under reducing conditions.4Additional reported (for the relevant formats) applications include: immunohistochemical staining of acetone-fixed frozen sections, immunoprecipitation1, and immunofluorescence3.

TotalSeq™-C0380 anti-rat CD90/mouse CD90.1 (Thy1.1) Antibody, CD90/CD90.1, OX-7, BioLegend, 202551

The OX-7 antibody reacts with rat CD90 and mouse CD90.1 (Thy-1.1) (which is expressed by mouse strains of AKR/J, PL, and FVB/N), but not mouse CD90.2.Additional reported applications (for the relevant formats) include: immunohistochemical7and immunofluorescent8staining of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, immunoprecipitation1, Western blotting1,in vitroactivation of leukocytes2, induction of endothelial cell permeability3, induction of apoptosis in glomerular mesangial cells, and induction of glomerulonephritisin vivo4.

Biotin Anti-CD90 / Thy1 antibody [5E10], Abcam, AB134361

Biotin Anti-CD90 / Thy1 antibody [EPR3132], Abcam, AB323685

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Biotin Anti-CD90 / Thy1 antibody [G7], Abcam, AB25285

ab25285 has been reported to promote apoptosis of thymocytes and CTL clones, and to mediate adhesion of thymocytes to thymic stroma.